Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-17

Clinical Trial Update: Clinical and Ultrasound Incidence of Rheumatologic Immune Related Adverse Events in Stage IIB-IV Melanoma Patients

View source ↗

Summary

A clinical trial update assessing the clinical and ultrasound incidence of rheumatologic immune-related adverse events in melanoma patients with stage IIb throu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Melanoma, Stage II, Melanoma Stage III | Status: NOT_YET_RECRUITING